MNX internals
| ||||||||||||||||||||||||||||
| Parent-child relations graph |
|
|||||||||||||||||||||||||||
| Identifier | Description |
|---|---|
vmhM:digalside_hs vmhM:digalside_hs vmhmetabolite:digalside_hs vmhmetabolite:digalside_hs YVBUQOZKCCPFCZ-KJHPJAPOSA-N | Digalactosylceramide (9Z)-N-[(4Z)-1-{[(2R,3R,4R,5R,6R)-3,4-dihydroxy-6-(hydroxymethyl)-5-{[(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl]oxy}-3-hydroxyoctadec-4-en-2-yl]octadec-9-enimidate 1-O-(4-O-alpha-D-Galactopyranosyl-beta-D-galactopyranosyl)-ceramide 1-O-(4-O-alpha-delta-Galactopyranosyl-beta-delta-galactopyranosyl)-ceramide Cell signaling agent Cellular membrane Cytoplasma Dietary supplement Digalactosylceramide Digestion Extracellular region Fauna Gal-alpha1->4gal-beta1->1'cer Golgi apparatus Golgi complex Golgi ribbon Kidneys Lipid metabolic process Membrane integrity agent Membrane stability agent Nutraceutical Signal transduction Signaling agent Signalling molecule Surface-active agent |
| hmdb:HMDB0004832 YVBUQOZKCCPFCZ-VTAAUCPCSA-N | Galabiosylceramide (d18:1/9Z-18:1) (9Z)-N-[(4Z)-1-{[(2R,3R,4R,5R,6R)-3,4-dihydroxy-6-(hydroxymethyl)-5-{[(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl]oxy}-3-hydroxyoctadec-4-en-2-yl]octadec-9-enamide (9Z)-N-[(4Z)-1-{[(2R,3R,4R,5R,6R)-3,4-dihydroxy-6-(hydroxymethyl)-5-{[(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl]oxy}-3-hydroxyoctadec-4-en-2-yl]octadec-9-enimidate 1-O-(4-O-alpha-D-Galactopyranosyl-beta-D-galactopyranosyl)-ceramide 1-O-(4-O-alpha-delta-Galactopyranosyl-beta-delta-galactopyranosyl)-ceramide Digalactosylceramide Gal-alpha1->4gal-beta1->1'cer |
hmdb:HMDB04832 vmhM:M_digalside_hs | secondary/obsolete/fantasy identifier |